Fuji Film Transfers Toyama Chemical Shares To Taisho Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Fuji Film and Taisho Pharmaceutical confirmed Oct. 24 their holding ratios of Toyoma Chemical shares, the company they jointly purchased in February. Taisho has increased investment to acquire some shares that were held by Fuji Film, which agreed to transfer the shares to Taisho to achieve their planned holding ratio of 66 percent for Fuji and 34 percent for Taisho. The two companies completed the takeover bid for Toyama Oct. 16 but did not announce the amount of payment. (Click here for more - Japanese language
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.